# LENZ Therapeutics, Inc.: filings

LENZ · Nasdaq · CIK 1815776 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lenz.md) · [Financials](/companies/lenz/financials.md) · [Filings](/companies/lenz/filings.md) · [Insiders](/companies/lenz/insiders.md)

## Reports and events: 105 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 98, 8-K 57, 3 29, 10-Q 16, 424B3 14, CORRESP 14, UPLOAD 11, EFFECT 9, SC 13G/A 9, SC 13G 8, SCHEDULE 13D/A 8, S-8 6, SCHEDULE 13G/A 6, 10-K 5, 425 5, DEF 14A 4, DEFA14A 4, S-1/A 4, SCHEDULE 13G 4, SEC STAFF LETTER 4, ARS 3, S-1 3, S-3 3, S-4/A 3, SC 13D/A 3, 8-K/A 2, POS AM 2, SC 13D 2, 10-K/A 1, 144 1, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, S-1MEF 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 20:13 ET | [10-Q](/filings/0001815776-26-000052.md) | Quarterly report, period 2026-06-30 | 0001815776-26-000052 |
| 2026-08-11 | 20:08 ET | [8-K](/filings/0001815776-26-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-26-000051 |
| 2026-07-02 | 21:00 ET | [8-K](/filings/0001815776-26-000046.md) | 5.02 Departure or appointment of officers or directors | 0001815776-26-000046 |
| 2026-06-12 | 20:08 ET | [8-K](/filings/0001815776-26-000041.md) | 5.07 Shareholder vote results | 0001815776-26-000041 |
| 2026-05-11 | 20:10 ET | [10-Q](/filings/0001815776-26-000037.md) | Quarterly report, period 2026-03-31 | 0001815776-26-000037 |
| 2026-05-11 | 20:07 ET | [8-K](/filings/0001815776-26-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-26-000035 |
| 2026-04-28 | 20:39 ET | [DEF 14A](/filings/0001815776-26-000026.md) | Proxy statement, period 2026-06-12 | 0001815776-26-000026 |
| 2026-03-24 | 20:10 ET | [10-K](/filings/0001815776-26-000011.md) | Annual report, period 2025-12-31 | 0001815776-26-000011 |
| 2026-03-24 | 12:10 ET | [8-K](/filings/0001815776-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-26-000008 |
| 2026-01-07 | 22:10 ET | [8-K](/filings/0001815776-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-26-000003 |
| 2025-12-12 | 21:15 ET | [8-K](/filings/0001815776-25-000077.md) | 8.01 Other events | 0001815776-25-000077 |
| 2025-11-10 | 21:48 ET | [SCHEDULE 13D/A](/filings/0001193125-25-274461.md) | Ownership report, active investor, amended | 0001193125-25-274461 |
| 2025-11-07 | 21:47 ET | [SCHEDULE 13D/A](/filings/0001346824-25-000043.md) | Ownership report, active investor, amended | 0001346824-25-000043 |
| 2025-11-05 | 21:10 ET | [10-Q](/filings/0001815776-25-000071.md) | Quarterly report, period 2025-09-30 | 0001815776-25-000071 |
| 2025-11-05 | 13:23 ET | [8-K](/filings/0001815776-25-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-25-000069 |
| 2025-10-08 | 20:40 ET | [8-K](/filings/0001815776-25-000064.md) | 8.01 Other events | 0001815776-25-000064 |
| 2025-09-30 | 12:06 ET | [8-K](/filings/0001815776-25-000062.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-25-000062 |
| 2025-09-22 | 20:20 ET | [SCHEDULE 13D/A](/filings/0001193125-25-211357.md) | Ownership report, active investor, amended | 0001193125-25-211357 |
| 2025-08-20 | 21:13 ET | [SCHEDULE 13D/A](/filings/0000950170-25-110483.md) | Ownership report, active investor, amended | 0000950170-25-110483 |
| 2025-07-31 | 20:55 ET | [8-K](/filings/0001815776-25-000059.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-25-000059 |
| 2025-07-30 | 20:03 ET | [10-Q](/filings/0001815776-25-000056.md) | Quarterly report, period 2025-06-30 | 0001815776-25-000056 |
| 2025-07-30 | 12:03 ET | [8-K](/filings/0001815776-25-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-25-000054 |
| 2025-07-14 | 20:50 ET | [SCHEDULE 13D/A](/filings/0000950170-25-095617.md) | Ownership report, active investor, amended | 0000950170-25-095617 |
| 2025-06-24 | 20:21 ET | [SCHEDULE 13D/A](/filings/0000950170-25-089455.md) | Ownership report, active investor, amended | 0000950170-25-089455 |
| 2025-06-12 | 20:49 ET | [SCHEDULE 13D/A](/filings/0000950170-25-085511.md) | Ownership report, active investor, amended | 0000950170-25-085511 |
| 2025-06-10 | 20:55 ET | [8-K](/filings/0001815776-25-000036.md) | 5.07 Shareholder vote results | 0001815776-25-000036 |
| 2025-05-09 | 20:19 ET | [SCHEDULE 13D/A](/filings/0001415889-25-012499.md) | Ownership report, active investor, amended | 0001415889-25-012499 |
| 2025-05-07 | 20:16 ET | [10-Q](/filings/0001815776-25-000032.md) | Quarterly report, period 2025-03-31 | 0001815776-25-000032 |
| 2025-05-07 | 20:09 ET | [8-K](/filings/0001815776-25-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-25-000030 |
| 2025-04-28 | 20:30 ET | [DEF 14A](/filings/0001193125-25-100630.md) | Proxy statement, period 2025-06-10 | 0001193125-25-100630 |
| 2025-04-15 | 12:37 ET | [8-K](/filings/0001815776-25-000025.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events | 0001815776-25-000025 |
| 2025-04-04 | 20:54 ET | [8-K](/filings/0001628280-25-016824.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-016824 |
| 2025-03-19 | 20:38 ET | [10-K](/filings/0001815776-25-000019.md) | Annual report, period 2024-12-31 | 0001815776-25-000019 |
| 2025-03-19 | 20:08 ET | [8-K](/filings/0001815776-25-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-25-000017 |
| 2024-11-08 | 22:08 ET | [SC 13D/A](/filings/0001193125-24-254239.md) | Ownership report, active investor, amended | 0001193125-24-254239 |
| 2024-11-06 | 12:35 ET | [10-Q](/filings/0001815776-24-000071.md) | Quarterly report, period 2024-09-30 | 0001815776-24-000071 |
| 2024-11-06 | 12:26 ET | [8-K](/filings/0001815776-24-000069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-24-000069 |
| 2024-10-28 | 12:09 ET | [8-K](/filings/0001815776-24-000064.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-24-000064 |
| 2024-09-11 | 20:09 ET | [S-1](/filings/0001628280-24-040130.md) | Registration statement | 0001628280-24-040130 |
| 2024-08-14 | 20:15 ET | [10-Q](/filings/0001815776-24-000060.md) | Quarterly report, period 2024-06-30 | 0001815776-24-000060 |
| 2024-08-14 | 20:08 ET | [8-K](/filings/0001815776-24-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-24-000058 |
| 2024-08-12 | 12:05 ET | [8-K](/filings/0001815776-24-000053.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-24-000053 |
| 2024-07-15 | 12:22 ET | [8-K](/filings/0001815776-24-000049.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001815776-24-000049 |
| 2024-05-08 | 21:11 ET | [10-Q](/filings/0001815776-24-000042.md) | Quarterly report, period 2024-03-31 | 0001815776-24-000042 |
| 2024-05-08 | 20:05 ET | [8-K](/filings/0001815776-24-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001815776-24-000039 |
| 2024-04-09 | 22:36 ET | [S-1/A](/filings/0001628280-24-015318.md) | Registration statement, amended | 0001628280-24-015318 |
| 2024-04-03 | 11:32 ET | [8-K](/filings/0001815776-24-000035.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001815776-24-000035 |
| 2024-03-29 | 20:46 ET | [S-1](/filings/0001628280-24-013816.md) | Registration statement | 0001628280-24-013816 |
| 2024-03-28 | 20:16 ET | [SC 13D](/filings/0001104659-24-040539.md) | Ownership report, active investor | 0001104659-24-040539 |
| 2024-03-25 | 20:43 ET | [SC 13D/A](/filings/0001193125-24-076566.md) | Ownership report, active investor, amended | 0001193125-24-076566 |

Page 1 of 3. [Older](/companies/lenz/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.